For decades, exercise has been viewed as supportive care for cancer patients—a way to improve strength, reduce fatigue, and enhance quality of life. But emerging research now suggests something much bigger: exercise may function as a true biologic therapy capable of influencing the tumor microenvironment, strengthening immune surveillance, and improving cancer outcomes.
In a recent CancerNetwork interview, integrative medicine physician Dr. Nathan Goodyear described exercise as a “biologically interventional therapy” for cancer. This represents a major shift in how oncology may eventually view physical activity—not simply as wellness advice, but as a scientifically grounded component of treatment itself.
One of the most important concepts discussed in the article is that declining physical fitness may be an early warning sign of worsening cancer biology. According to Goodyear, inactivity contributes to immune exhaustion, chronic inflammation, and immunosenescence—the aging and weakening of the immune system. These changes may accelerate tumor progression long before cancer growth becomes visible on imaging scans.
The scientific evidence supporting exercise oncology continues to grow rapidly.
The landmark CHALLENGE trial demonstrated that patients with stage II and III colorectal cancer who participated in a structured exercise program experienced lower recurrence rates and lower risks of death compared with patients receiving only general lifestyle advice. Remarkably, the exercise intervention involved only moderate activity performed several times weekly—not extreme athletic training.
Another important study, the OPTIMUS trial, provided insight into how exercise may work biologically. Researchers found that exercise increased CD8-positive T-cell infiltration into tumors while reducing immunosuppressive cells. In simple terms, exercise appeared to help activate the immune system against cancer. Investigators suggested that exercise may even help convert “cold” tumors into “hot” tumors that are more responsive to treatment and immune attack.
Importantly, this article emphasizes that exercise must be individualized. A frail patient with advanced cancer may benefit simply from increased mobility and light movement, while a fitter survivor may safely incorporate resistance training and cardiovascular conditioning. Exercise oncology is not “one size fits all.”
At CancerFitness.org, we believe these findings reinforce an urgent message for patients, oncologists, surgeons, healthcare systems, and cancer centers worldwide:
Exercise oncology should no longer be viewed as optional supportive care. It should increasingly become part of comprehensive cancer treatment planning.
Call to Action
If you are a cancer patient or survivor, ask your oncology team about structured exercise programs tailored to your condition and treatment stage.
If you are a healthcare provider, begin incorporating exercise assessment and referral into routine cancer care.
The science is evolving rapidly—and the evidence increasingly suggests that movement may be one of the most powerful adjunctive therapies available in modern oncology.
Reference: www.cancernetwork.com/view/outlining-exercise-as-a-biologically-interventional-therapy-for-cancer
